Akari Therapeutics, Plc

DB:CLA Stock Report

Market Cap: €26.7m

Akari Therapeutics, Plc Company Information

Akari Therapeutics, Plc's employee growth, exchange listings and data sources

Key Information

  • Name: Akari Therapeutics, Plc
  • Ticker: CLA
  • Exchange: DB
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$28.225m
  • Listing Market Cap: US$26.715m
  • Shares Outstanding: 24.76m
  • Website: https://www.akaritx.com

Number of Employees

Location

  • Akari Therapeutics, Plc
  • 22 Boston Wharf Road
  • Floor 7
  • Boston
  • Massachusetts
  • 02210
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AKTXNasdaqCM (Nasdaq Capital Market)YesSPON ADR EACH REPR 2000 ORDUSUSDJun 2014
CLADB (Deutsche Boerse AG)YesSPON ADR EACH REPR 2000 ORDDEEURJun 2014

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/27 20:15
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.